Upjohn/Rorer
Executive Summary
Marketing agreement expanded, giving Upjohn certain marketing rights outside the U.S. to Rorer's cardioselective beta blocker Selectol (celiprolol) and Frumil co-marketing rights in West Germany, France, Italy and Spain. The two companies recently agreed to co-promote Ansaid and celiprolol in the U.S. ("The Pink Sheet" July 24, T&G-5).